PCA
PTCT icon

Private Capital Advisors’s PTC Therapeutics PTCT Stock Holding History

Private Capital Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,983
Closed -$2.66M – 82
2026
Q1 		$2.66M Buy
38,983
+9,870
+34% +$699K 0.3% 31
2025
Q4 		$2.21M Buy
29,113
+13,051
+81% +$948K 0.23% 35
2025
Q3 		$986K Buy
+16,062
New +$837K 0.11% 44

Other funds holding PTCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Private Capital Advisors's PTCT Position: Q2 2026 in Review

Private Capital Advisors sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 38,983 shares — an estimated $2.66M sold.

Private Capital Advisors first reported a position in PTCT in Q3 2025 and held it in 3 quarters. The position peaked at $2.66M in Q1 2026. 69 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Private Capital Advisors reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Private Capital Advisors sold 38,983 PTC Therapeutics shares in Q2 2026, an estimated $2.66M.
  • Private Capital Advisors first reported a position in PTC Therapeutics in Q3 2025 and held it in 3 quarters.
  • Private Capital Advisors's PTC Therapeutics position peaked at $2.66M in Q1 2026.
  • 69 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.